GILEAD SCIENCES INC
10-Q, EX-27, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GILEAD SCIENCES INC, 10-Q, 2000-08-14
Next: PROTEIN DESIGN LABS INC/DE, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEETS AND CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS FOUND ON PAGES 3 AND 4 OF THE COMPANY'S FORM 10-Q FOR THE PERIOD
ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          42,740
<SECURITIES>                                   252,807
<RECEIVABLES>                                   46,644<F1>
<ALLOWANCES>                                         0
<INVENTORY>                                     20,292
<CURRENT-ASSETS>                               371,447
<PP&E>                                          51,771<F2>
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 436,537
<CURRENT-LIABILITIES>                           44,630
<BONDS>                                         83,378
                                0
                                          0
<COMMON>                                            45
<OTHER-SE>                                     302,162
<TOTAL-LIABILITY-AND-EQUITY>                   436,537
<SALES>                                         74,334
<TOTAL-REVENUES>                                95,201
<CGS>                                           16,631
<TOTAL-COSTS>                                  107,927
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               3,055
<INCOME-PRETAX>                                (7,476)
<INCOME-TAX>                                       832
<INCOME-CONTINUING>                            (9,947)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (9,947)
<EPS-BASIC>                                     (0.22)
<EPS-DILUTED>                                   (0.22)
<FN>
<F1>RECEIVABLES IS NET OF AN ALLOWANCE FOR DOUBTFUL ACCOUNTS.
<F2>PP&E IS NET OF ACCUMULATED DEPRECIATION.
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission